PEDIATRICS Vol. 107 No. 6 June 2001, p. e90
ELECTRONIC ARTICLE:
Impact of the Change to Inactivated Poliovirus Vaccine on the
Immunization Status of Young Children in the United States: A Study
From Pediatric Research in Office Settings and the National Medical
Association
Received Oct 18, 2000; accepted Jan 17, 2001.
,
,
From the * Department of Pediatrics, University of Washington,
Seattle, Washington; Objective. To determine whether the
change from an all oral poliovirus vaccine (OPV) schedule to an
inactivated poliovirus vaccine (IPV)-containing schedule has adversely
affected the immunization status of young children in the United
States.
Methods. Immunization data were abstracted from the
medical records of children 8 to 35 months old seen consecutively for
any reason in the offices of practicing pediatricians who are members
of the Pediatric Research in Office Settings network of the American Academy of Pediatrics or the National Medical Association. Data on up
to 120 eligible children were collected in each practice between March
1998 and January 2000. Patients were classified as fully immunized at 8 months old if they had received 3 diphtheria-tetanus-pertussis, 2 Haemophilus influenzae type b, 2 hepatitis B, and 2 poliovirus vaccines. Study children who were Results. Data were analyzed on 13 520 children from 177 practices in 42 states; 79.4% of patients were fully immunized at 8 months of age, and 88.7% of those eligible were fully immunized at 12 months of age. A total of 6910 patients (51.1%) were classified as OPV
recipients, wheras 5282 (39.1%) received IPV. In addition, 1328 children (9.8%) were documented as having received poliovirus vaccine,
but the particular type could not be determined. Compared with OPV
recipients and after controlling for the confounding variables and the
effect of clustering within practices, children in the IPV group were
as likely as were OPV recipients to be fully immunized at 8 months of
age (OR: 1.04; 95% CI: 0.88,1.23). At 12 months of age, the OR for IPV
as a predictor of being fully immunized was 1.08 (95% CI: 0.90,1.30).
When compared with OPV recipients, adjusted ORs for children in the
undetermined poliovirus vaccine type group being fully immunized at 8 and 12 months of age were 0.84 (95% CI: 0.68,1.04) and 0.84 (95% CI:
0.67,1.07), respectively.
Conclusions. The results of this national study indicate
that the implementation of an IPV-containing poliovirus vaccine
schedule has not had an adverse effect on the immunization status of
young children who were vaccinated in the offices of practicing
pediatricians.
Department of Pediatrics, Medical University of
South Carolina, Charleston, South Carolina; § Department of Pediatrics,
Johns Hopkins University, Baltimore, Maryland;
Pediatric and
Adolescent Care, Tulsa, Oklahoma; ¶ Division of Primary Care Research,
American Academy of Pediatrics, Elk Grove, Illinois; and # Department of
Pediatrics, University of Vermont, Burlington, Vermont.
12 months of age at the
time that data were collected were categorized as being fully immunized at 12 months if they had received the same vaccines before their first
birthday. To assess the effect of type of poliovirus vaccines on these
outcomes, study patients were classified as being in an IPV or OPV
group based on the initial type of vaccine received. Logistic
regression was used to calculate the odds ratios (ORs) and 95%
confidence intervals (CIs) for IPV as a predictor of being fully
immunized at 8 and 12 months of age, after adjusting for race/ethnicity
of the patient, maternal education level, year of birth, and method of
payment for vaccines. In addition, the effect of clustering of children
within practices was accounted for by the use of generalized estimation
equation techniques.
This article has been cited by other articles:
![]() |
E. G. Flaherty, R. D. Sege, J. Griffith, L. L. Price, R. Wasserman, E. Slora, N. Dhepyasuwan, D. Harris, D. Norton, M. L. Angelilli, et al. From Suspicion of Physical Child Abuse to Reporting: Primary Care Clinician Decision-Making Pediatrics, September 1, 2008; 122(3): 611 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Lee, J. A. Finkelstein, I. L. Miroshnik, D. Rusinak, J. M. Santoli, S. M. Lett, and T. A. Lieu Pediatricians' Self-reported Clinical Practices and Adherence to National Immunization Guidelines After the Introduction of Pneumococcal Conjugate Vaccine Arch Pediatr Adolesc Med, July 1, 2004; 158(7): 695 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
Study: Switch to IPV didn't hurt immunization rates AAP News, July 1, 2002; 21(1): 20 - 20. [Full Text] [PDF] |
||||







